Evidence map›Paper›PMID 19105617›Full record

ReviewRegenerative medicine2009

Update on therapeutic vascularization strategies.

Edward A Phelps, Andres J Garcia

Abstract readReview
In one paragraph

Review in Regenerative medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 137 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Cell seeding accelerates the vascularization of tissue engineering constructs in hypertensive mice.Hypertension research : official journal of the Japanese Society of Hypertension · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Noninvasive PET Imaging and Tracking of Engineered Human Muscle Precursor Cells for Skeletal Muscle Tissue Engineering.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2016
    Article
  18. Article
  19. Article
  20. Controlled Angiogenesis in Peptide Nanofiber Composite Hydrogels.ACS biomaterials science & engineering · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Edward A PhelpsWoodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA.
Andres J Garcia
Georgia Institute of Technology · US

Funding

Integrin-specific implant surfaces for bone repairR01EB004496 · NIBIB · GEORGIA INSTITUTE OF TECHNOLOGY · PI GARCIA, ANDRES J · 2005 to 2008
$1.4M
NIBIB NIH HHS R01 EB004496
6 · The paper itself

Abstract

The ability to exploit angiogenesis and vascularization as a therapeutic strategy will be of enormous benefit to a wide range of medical and tissue-engineering applications. Angiogenic growth factor and cell-based therapies have thus far failed to produce a robust healing response in clinical trials for a variety of ischemic diseases, while engineered tissue substitutes are still size-limited by a lack of vascularization. The purpose of this review is to investigate current research advances in therapeutic vascularization strategies applied to ischemic disease states, tissue engineering and regenerative medicine. Recent advances are discussed that focus on better regulation of growth factor delivery and attempts to better mimic natural processes by delivering combinations of multiple growth factors, cells and bioactive materials in the right spatial and temporal setting. Some unconventional approaches and novel therapeutic targets that hold significant potential are also discussed.

Indexed as

Angiogenesis Inducing AgentsAnimalsBiocompatible MaterialsCell- and Tissue-Based TherapyHumansIntercellular Signaling Peptides and ProteinsIschemiaModels, BiologicalNeovascularization, PathologicTissue EngineeringAngiogenesis Inducing AgentsBiocompatible MaterialsIntercellular Signaling Peptides and Proteins

Identifiers

PMID19105617
PMCPMC2644334
OpenAlexW2087694306

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.